A platform to enhance cancer treatment using focused ultrasound technology
A turnkey research platform to accelerate clinical translation of targeted immune-modulation enhanced therapies
This study is exploring a new way to use focused ultrasound to make cancer treatments, like immunotherapy, work better, aiming to create a simple system that could lead to less invasive and more effective options for patients.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sonovol, INC. NIH-funded |
| Lab location | 1 site (Durham, UNITED STATES) |
| Project ID | NIH-10458077 on NIH RePORTER |
What this research studies
This research focuses on developing a new platform that utilizes focused ultrasound (FUS) technology to improve cancer treatment outcomes. By combining FUS with existing therapies like immunotherapy, the goal is to enhance the effectiveness of these treatments and better modulate the tumor environment. The research aims to create a user-friendly system that allows for precise delivery of FUS in preclinical settings, which could lead to significant advancements in cancer therapy. Patients may benefit from improved treatment options that are less invasive and potentially more effective.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with various types of cancer who are seeking innovative treatment options.
Not a fit: Patients with non-malignant conditions or those who are not eligible for cancer therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments that improve patient outcomes and reduce the need for invasive procedures.
How similar studies have performed: Previous research has shown promise in using focused ultrasound in combination with immunotherapy, indicating potential for success in this novel approach.
Where this research is happening
Durham, UNITED STATES
- Sonovol, INC. — Durham, United States (Active)
Researchers
- Principal investigator: Gessner, Ryan — Sonovol, INC.
- Study coordinator: Gessner, Ryan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.